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We present a case of a 66-year-old man with esophageal carcinoma. 18Fluorodeoxyglucose positron 
emission tomography/computed tomography (18F-FDG PET/CT) for evaluating distant metastasis and 
staging revealed 18F-FDG uptake in the third lumbar vertebra and other vertebrae. Magnetic resonance 
imaging could not diﬀerentiate bone metastases from benign bone lesions. We considered the possibility 
of bone marrow reconversion. 111Indium chloride (111In-Cl3) scintigraphy with single-photon emission 
computed tomography/computed tomography (SPECT/CT) revealed erythroid bone marrow compo-
nents in the bone lesions. The diagnosis of bone marrow reconversion was pathologically conﬁrmed by 
a bone biopsy of the third lumbar vertebra. The patient underwent esophagectomy and has remained 
disease-free in the 2 years since. To the best of our knowledge, this is the ﬁrst report to describe the 
usefulness of 111In-Cl3 with SPECT/CT for the diagnosis of bone marrow reconversion.
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18 Fluorodeoxyglucose positron emission tomogra-phy/computed tomography (18F-FDG PET/
CT) has become an acceptable and established diag-
nostic tool for both cancer diagnosis and staging.  
Benign bone lesions such as bone marrow reconversion 
are sometimes confused with bone metastasis on 18F-
FDG PET/CT and magnetic resonance imaging 
(MRI) [1,  2].  We report a case of bone marrow 
reconversion that mimicked bone metastasis in a 
patient with esophageal carcinoma,  and demonstrate 
that 111Indium chloride (111In-Cl3) with single-photon 
emission computed tomography/CT can contribute to 
the diagnosis of bone marrow reconversion.
　 To the best of our knowledge,  this is the ﬁrst 
report to describe the usefulness of 111In-Cl3 with 
SPECT/CT for the diagnosis of bone marrow recon-
version.
Case Report
　 A 66-year-old man (height 154cm,  body weight 
62.9kg) with a history of heavy smoking and alcohol-
induced cirrhosis was referred to our hospital for 
treatment of esophageal squamous cell carcinoma.  He 
had no clinical symptoms such as abdominal pain or 
lumbago.  His blood pressure was 134/71mmHg,  pulse 
was 89 beats/min and oxygen saturation on room air 
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was 99 .  The results of his physical examination 
were normal.  The results of laboratory examinations,  
including white blood cell count,  platelet count,  and 
levels of hemoglobin,  C-reactive protein,  alkaline 
phosphatase,  and lactate dehydrogenase were within 
the normal ranges.  Levels of tumor markers,  including 
squamous cell carcinoma antigen and carcinoembryonic 
antigen,  were within normal limits.  The patientʼs 
serum carbohydrate antigen 19-9 level was slightly 
elevated (69.8U/mL).  Upper gastrointestinal endos-
copy and biopsy showed two 35-mm type 0-IIc moder-
ately diﬀerentiated squamous cell carcinoma lesions in 
the upper third of the esophagus. 
　 A CT scan showed no obvious distant metastases 
but revealed slightly enlarged lymph nodes in the 
recurrent laryngeal nerve regions on both sides. 18F-
FDG PET/CT for the evaluation of distant metastasis 
and staging showed accumulations of 18F-FDG in the 
main tumors and no signiﬁcant accumulation of 18F-
FDG in the mediastinal lymph nodes, but there was 
18F-FDG uptake in the third lumbar (L3) vertebra 
(maximum standardized uptake value [SUVmax]: 4.12) 
and subtle uptake in the other vertebrae (arrowhead) 
(Fig. 1). 
　 On the CT images obtained by an integrated 18F-
FDG PET/CT scanner, this uptake corresponded 
with a slightly high-attenuation bone lesion with pre-
served bone trabeculae (not shown). MRI of the spine 
showed a hyperintense bone lesion on short tau inver-
sion recovery (STIR) images and a hypointense lesion 
on T1-and T2-weighted images of the L3 vertebra 
(Fig. 2, arrows). Fat-saturated T1-weighted images 
after gadolinium administration showed diﬀuse enhance-
ment of the L3 vertebral lesion. Focal bone lesions 
with similar MR signal features were detected in the 
other lumbar vertebrae (Fig. 2, arrowheads). Normal 
fatty marrow was seen in the background of the spine. 
We considered the possibility of bone marrow recon-
version of the L3 vertebra. For further evaluation, 
111In-Cl3 scintigraphy with SPECT/CT was performed 
48 h after intravenous injection of 74 MBq of 111In-Cl3 
using a dual-head camera (GE Discovery NM/CT 670, 
GE Healthcare, Waukesha, WI, USA). Planar and 
SPECT/CT scintigraphy showed an abnormal increase 
in tracer uptake in the L3 vertebra (arrows) and sub-
tle uptake in the other vertebrae (arrowhead) (Fig. 3). 
The 111In-Cl3 uptake pattern detected by SPECT/CT 
was similar to the 18F-FDG uptake pattern corre-
sponding to the bone lesions on MRI. On the basis of 
these imaging features, bone marrow reconversion was 
strongly suspected. However, to conﬁrm bone marrow 
reconversion, a CT-guided bone biopsy with a 13- 
gauge bone biopsy needle was taken from the L3 ver-
tebral lesion. Histological examination did not reveal 
any cancer cells, but did show hypercellular bone 
marrow (Fig. 4). The patient underwent esophagec-
tomy. Histological examination from the resected 
specimen showed that moderately diﬀerentiated squa-
mous cell carcinoma had invaded the submucosal layer 
(the middle third) with mild venous invasion, but 
detected no lymphatic invasion or lymph node metasta-
sis. The patient has been regularly followed up and 
remains disease-free 2 years after surgery.
Discussion
　 At birth, hematopoietic (red) bone marrow is pres-
ent throughout the entire skeleton, but then starts to 
convert to fatty (yellow) bone marrow [3]. This matu-
ration process typically progresses from the periph-
eral to the central skeleton and is usually completed 
by the age of 25 years, although its speed depends on 
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Fig.  1　 18Fluorodeoxyglucose positron emission tomography/
computed tomography (18F-FDG PET/CT) ﬁndings.  A sagittal 
reconstructed 18F-FDG PET/CT image showing high uptake in the 
third lumbar (L3) vertebral body (arrow) and subtle uptake in the 
other vertebrae (arrowhead).  The maximum standardized uptake 
value (SUVmax) of the L3 vertebra was 4.12.
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Fig.  2　 Magnetic resonance imaging (MRI) ﬁndings.  Sagittal T1-weighted (A) and T2-weighted (B) spin-echo MR images of the thora-
columbar spine showing a focal hypointense lesion in the L3 vertebral body (arrows).  Sagittal short tau inversion recovery (STIR) image (C) 
and fat-saturated T1-weighted image after gadolinium administration (D) showing a hyperintense lesion with contrast enhancement in the 
L3 vertebral body (arrows).  Patchy focal bone lesions with similar signal features to the L3 bone lesion were detected in the other lumbar 
vertebrae (arrowheads).
Fig.  3　 111Indium chloride (111In-Cl3) scintigraphy with single-photon emission computed tomography/computed tomography (SPECT/CT) 
ﬁndings.  The posterior planar (A) and SPECT/CT (B coronal) scintigraphy images showing abnormal increase in tracer uptake in the L3 
vertebra (arrows) and subtle uptake in the other vertebrae (arrowhead).  The 111In-Cl3 uptake pattern detected by SPECT/CT was similar to 
the 18F-FDG uptake pattern corresponding to the bone lesions on MRI.
an individualʼs sex and underlying medical conditions. 
Red marrow consists of 40  water, 40  fat, and 20
protein, whereas yellow marrow consists of 15  
water, 80  fat, and 5  protein [4]. In normal adult 
marrow, yellow marrow may reconvert to the marrow 
under conditions that cause a need for increased hema-
topoiesis. This reconversion may have several causes, 
including stress, obesity, middle age (in women), heavy 
smoking, long-distance running, high-altitude living, 
obstructive sleep apnea syndrome, chronic anemia, and 
administration of hematopoietic growth factors [3, 4]. 
The reconversion process proceeds in the reverse 
pattern of the original red-to-yellow conversion. It may 
occur diﬀusely, or focal areas of the red marrow may 
appear in a background of the yellow marrow [2, 3]. 
In our patient, a smoking history may have contributed 
to the progression of bone marrow reconversion. 
　 Several imaging modalities, such as bone scintigra-
phy, CT, MRI, and 18F-FDG PET/CT, are used to 
evaluate bone lesions. Currently, MRI and 18F-FDG 
PET/CT have been playing important roles in the 
detection and evaluation of bone metastases. However, 
bone marrow reconversion is sometimes misdiagnosed 
as bone metastasis because of its high cellularity, 
although in some cases non-neoplastic bone lesions can 
be easily diﬀerentiated from neoplastic lesions on MR 
images such as in-phase and out-of-phase gradient-echo 
MR imaging [5]. Reconverted bone marrow may show 
a masslike pattern with high cellularity and MR signal 
characteristics of hypercellular hematopoietic marrow, 
and those of tumor inﬁltration or highly cellular neo-
plastic bone marrow can be similar [2, 6]. Like MRI, 
18F-FDG PET/CT may give false-positive results for 
bone metastasis [1]. A previous report evaluating 
imaging features of hyperplastic hematopoietic bone 
marrow and bone metastasis showed that if the 
SUVmax of a bone lesion was more than 3.6 on 18F-
FDG PET/CT, the lesion could be considered meta-
static [7]. In our case, the multiple bone lesions 
detected on 18F-FDG PET/CT and MRI were similar 
to tumor inﬁltrations caused by bone metastases, and 
we could not rule out the possibility of malignancy.
　 111In-Cl3 scintigraphy with SPECT/CT could be an 
additional diagnostic tool for focal bone marrow 
reconversion. 111In-Cl3 scintigraphy is a noninvasive 
method for evaluating the anatomic extent of the 
erythropoietic element. Iron radionuclides are ideal 
physiologically but are unsuitable for erythroid bone 
marrow scintigraphy because of their high-energy 
radiation. 111In-Cl3 has been used clinically as a reli-
able alternative tracer in bone marrow scintigraphy 
because of its transportation in the plasma by trans-
ferrin and its suitable energy characteristics [8]. 
After intravenous injection, 111In-Cl3 is rapidly coupled 
to serum transferrin and eliminated from the plasma 
with a half-life of 5h. Approximately 30  of the 
administered tracer is found in the bone marrow, 20  
in the liver, 7  in the kidneys, and 1  in the spleen. 
The remaining activity is distributed throughout the 
body ﬂuids without any speciﬁc tissue accumulation 
[9]. In previous reports, planar scintigraphy with 
111In-Cl3 was usually used to predict the clinical sever-
ity of diﬀuse bone marrow diseases such as myeloﬁ-
brosis, aplastic anemia, and myelodysplastic syndrome, 
particularly to detect the disappearance of a physio-
logically active bone marrow [8-10]. Planar scintigra-
phy alone is not suﬃcient to evaluate and diagnose 
focal bone lesions. A new hybrid imaging system, 
SPECT/CT, has advantages over planar imaging 
because it provides a more precise localization of 
lesions with focal tracer uptake and improves clinical 
diagnostic conﬁdence. In our case, 111In-Cl3 accumula-
tion detected by SPECT/CT conformed remarkably 
to the images of FDG-PET/CT and MRI, thus con-
tributing to the correct diagnosis.
　 We encountered a case of bone marrow reconver-
sion that mimicked bone metastasis in a patient with 
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Fig.  4　 Pathological ﬁndings.  Bone biopsy specimen of the L3 
vertebral lesion showed hypercellular bone marrow with a reduced 
proportion of adipocytes.  No neoplastic cells were seen (hematox-
ylin and eosin staining).
esophageal carcinoma. The bone marrow reconversion 
was ultimately diagnosed using a biopsy specimen. 
111In-Cl3 scintigraphy with SPECT/CT can contribute 
to the diagnosis of bone marrow reconversion.
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